Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults
and accounts for the largest number of annual deaths due to leukemias in the United States …

Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults
and accounts for the largest number of annual deaths due to leukemias in the United States …

Acute myeloid leukemia (AML) remains the most common form of acute leukemia among
adults and accounts for the largest number of annual deaths due to leukemias in the United …

The NCCN Guidelines for Acute Myeloid Leukemia (AML) provide recommendations for the
diagnosis and treatment of adults with AML based on clinical trials that have led to …

These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines
for Acute Myeloid Leukemia and discuss the clinical evidence that support the …

Overview I n 2010, approximately 12,330 people were diagnosed with and 8950 died of
acute myeloid leukemia (AML). 1 As the population ages, the incidence of AML, along with …

The NCCN Guidelines for Acute Lymphoblastic Leukemia (ALL) focus on the classification of
ALL subtypes based on immunophenotype and cytogenetic/molecular markers; risk …

The prognosis for patients with newly diagnosed acute lymphoblastic leukemia (ALL) has
improved with the use of more intensive chemotherapy regimens, tyrosine kinase inhibitors …

Treatment of acute lymphoblastic leukemia (ALL) continues to advance, as evidenced by the
improved risk stratification of patients and development of newer treatment options …

Disease overview Acute myeloid leukemia (AML) is a frequently fatal bone marrow stem cell
cancer characterized by unbridled proliferation of malignant marrow stem cells with …